Latest Drug Approvals news
FDA Approves New ALS Drug Despite Uncertain Data
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves SPEVIGO for Generalized Pustular Psoriasis Flares
posted September 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Imbruvica for Pediatric Chronic Graft Versus Host Disease
posted August 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes 
Short-Term Pretransplant Dialysis Does Not Affect Kidney Transplant Outcomes 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Lung Transplant Can Prolong Survival in Stage IV NSCLC Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
